We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Recently, West Interns from the Exton headquarters volunteered at the Thorncroft Equestrian Center in Malvern, Pennsylvania. Established in 1969, Thorncroft is a Therapeutic Equestrian Center that provides horseback riding to children and adults with mental, emotional and physical disabilities, with the mission to develop the physical and emotional well-being of all people, regardless of their individual challenges. As volunteers, the interns participated in various maintenance activities around the farm to help preserve and support the valuable experience that Thorncroft continually provides to our community.
The Thorncroft Equestrian Center functions as any farm would, with an endless amount of maintenance work needed to provide an enjoyable experience to both the people and horses alike. As members of the West Ambassador Internship Program, the 15 intern volunteers worked hard to assist the center in much needed work, including washing windows, installing a gate, painting, weeding, mulching and mucking stalls. Their volunteer work highlighted the selfless approach that the farm takes to providing therapy to their riders.
“I was surprised at all of the work it takes to maintain the farm and stables,” said Ashley Pyne, a finance intern at West. “I found it inspiring how the employees and volunteers at Thorncroft spend their everyday lives giving people with disabilities the chance to experience happiness through horseback riding.”
One West intern has a direct connection to Thorncroft, which contributed to the dedication and compassion towards her volunteer work. Samantha Elduff, a scientific affairs intern, has a family member that receives care from the equestrian center.
“Thorncroft is an incredible family that is devoted to creating an all-inclusive world. It was an honor to be part of such an honorable cause,” Samantha added.
Thorncroft believes that love and respect promote true healing and enable growth to occur, a feeling that was evident throughout the day, from the moment the interns arrived until their work was finished at the end of the day.
For more information on Our Culture of Giving click here.
Combination products open up new vistas when it comes to delivering innovative therapies to patients in need, but teams bringing these products to the market face a number of significant hurdles. Recent surveys conducted by West at workshops held in PA and AZ have revealed some of our customers’ biggest challenges. This is the first of three blogs focused on these challenges — and how West can help Simplify the Journey™ when it comes to developing a combination product.
The global prefilled syringe market is growing rapidly, and approximately 60% of prefilled syringes use staked needles. To help ensure the integrity of the drug products contained within, the majority of staked-needle prefilled syringes use Rigid Needle Shields (RNS).
The rise in type 2 diabetes has sparked a variety of treatment options, including glucagon-like peptide-1 (GLP-1) receptor agonists. GLP-1s are a class of injected drugs (additional oral options are currently in development) that “mimic the action of GLP-1 and increase the incretin effect in patients with type 2 diabetes, stimulating the release of insulin.”<sup>1</sup> Commonly used when oral treatment alone is not enough, the benefits of GLP-1s include a reduction of glucagon and glycosylated haemoglobin (HbA1c), weight loss and a low risk of hypoglycemia.<sup>2</sup>
Twelve weeks, 60 days, or 480 hours is all that I have in the summer of 2014 to showcase my talents as the Pharmaceutical Delivery Systems (PDS) Marketing and Innovation Ambassador Intern. To many, that might seem to be a rather extensive amount of time to become familiar with an organization, meet respective colleagues, learn about products and operations, and develop a means to an end for the designated project assignment that all Ambassadors receive every summer.
One of the challenges a drug manufacturer faces is controlling the drug product at the point-of-use in a hospital or clinical environment. Often the method of vial access is variable, leading to an increased risk of harmful patient outcomes such as stopper cores or fragments entering into the drug product, which can contribute to cardiovascular events. There are a number of causes that contribute to stopper coring and fragmentation in the field that depend primarily on the technique of the practitioner and the properties of the elastomeric closure.
English
Chinese
